• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2021 年美国健康中心提供的 HIV 暴露前预防措施。

HIV pre-exposure prophylaxis provision by U.S. health centers in 2021.

机构信息

Department of Global Health and Population, Harvard T.H. Chan School of Public Health.

The Fenway Institute, Fenway Health.

出版信息

AIDS. 2024 Mar 1;38(3):415-420. doi: 10.1097/QAD.0000000000003774. Epub 2023 Nov 21.

DOI:10.1097/QAD.0000000000003774
PMID:37905992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10842666/
Abstract

OBJECTIVES

The aim of this study was to assess HIV preexposure prophylaxis (PrEP) provision in U.S. health centers.

DESIGN

The U.S. Ending the HIV Epidemic (EHE) initiative designated health centers as the main healthcare system through which PrEP scale-up occurs. Health centers offer primary care to over 30 million disproportionately uninsured, racially or ethnically minoritized, and low-income patients. This study is the first to assess PrEP provision across health centers, including characteristics of clinics, patient populations, and policies associated with PrEP prescribing.

METHODS

The Health Resources and Services Administration's Uniform Data System contained aggregate data on PrEP prescriptions and patient sociodemographics at health centers from January 1 through December 31, 2021, in 50 U.S. states, the District of Columbia, and eight U.S. territories. We compared patient demographics and availability of Medicaid expansion and PrEP assistance programs at health centers that prescribed vs. those that did not prescribe PrEP.

RESULTS

Across 1375 health centers serving 30 193 278 patients, 79 163 patients were prescribed PrEP. Health centers that prescribed any PrEP had higher proportions of sexual, gender, racial, and ethnic minority patient populations compared with health centers that prescribed no PrEP. Compared with health centers that prescribed no PrEP, a higher proportion of health centers that prescribed PrEP were located in designated high-priority jurisdictions of the EHE initiative or states with Medicaid expansion or public PrEP assistance programs.

CONCLUSION

Health centers are critical for scaling up PrEP in minoritized populations disproportionately affected by HIV, facilitated through federal and state-level policies. These findings highlight service gaps and inform future interventions to optimize PrEP implementation and support EHE initiative goals.

摘要

目的

本研究旨在评估美国卫生中心提供的艾滋病毒暴露前预防(PrEP)。

设计

美国终结艾滋病毒流行(EHE)倡议指定卫生中心为主要医疗保健系统,通过该系统扩大 PrEP 的规模。卫生中心为数以百万计的没有保险、种族或族裔少数群体、低收入的患者提供初级保健。本研究首次评估了整个卫生中心的 PrEP 供应情况,包括诊所的特点、患者人群以及与 PrEP 处方相关的政策。

方法

卫生资源和服务管理局的统一数据系统包含了 2021 年 1 月 1 日至 12 月 31 日期间,50 个州、哥伦比亚特区和 8 个美国领土的卫生中心 PrEP 处方和患者社会人口统计学数据的汇总数据。我们比较了在有或没有开具 PrEP 处方的卫生中心,患者的人口统计学特征以及医疗补助扩大和 PrEP 援助计划的可用性。

结果

在为 30193278 名患者提供服务的 1375 个卫生中心中,有 79163 名患者开具了 PrEP 处方。与没有开具 PrEP 处方的卫生中心相比,开具任何 PrEP 处方的卫生中心的性、性别、种族和族裔少数患者人群比例更高。与没有开具 PrEP 处方的卫生中心相比,开具 PrEP 处方的卫生中心中有更高比例的卫生中心位于 EHE 倡议的指定高优先级司法管辖区,或在有医疗补助扩大或公共 PrEP 援助计划的州。

结论

卫生中心在为受艾滋病毒影响不成比例的少数群体扩大 PrEP 方面发挥了关键作用,这得益于联邦和州一级的政策。这些发现突出了服务差距,并为优化 PrEP 实施和支持 EHE 倡议目标提供了未来干预措施的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7540/10842666/fc868f62e45a/aids-38-415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7540/10842666/fc868f62e45a/aids-38-415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7540/10842666/fc868f62e45a/aids-38-415-g001.jpg

相似文献

1
HIV pre-exposure prophylaxis provision by U.S. health centers in 2021.2021 年美国健康中心提供的 HIV 暴露前预防措施。
AIDS. 2024 Mar 1;38(3):415-420. doi: 10.1097/QAD.0000000000003774. Epub 2023 Nov 21.
2
Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.县级预防前预防性覆盖估计方法及其在美国终结艾滋病毒流行司法管辖区的应用。
Ann Epidemiol. 2020 Apr;44:16-30. doi: 10.1016/j.annepidem.2020.01.004. Epub 2020 Jan 13.
3
Geographic variations of pre-exposure prophylaxis reversal and abandonment among United States counties.美国各县之间的暴露前预防逆转和放弃的地理差异。
AIDS. 2024 Mar 15;38(4):557-566. doi: 10.1097/QAD.0000000000003790. Epub 2023 Nov 15.
4
State-level clustering in PrEP implementation factors among family planning clinics in the Southern United States.南方美国计划生育诊所中实施 PrEP 因素的州级聚集。
Front Public Health. 2023 Jul 25;11:1214411. doi: 10.3389/fpubh.2023.1214411. eCollection 2023.
5
Toward Greater Pre-exposure Prophylaxis Equity: Increasing Provision and Uptake for Black and Hispanic/Latino Individuals in the U.S.实现更公平的暴露前预防措施:增加美国黑人和西班牙裔/拉丁裔个人的供应和使用率
Am J Prev Med. 2021 Nov;61(5 Suppl 1):S60-S72. doi: 10.1016/j.amepre.2021.05.027.
6
Health Care Providers' Views on Clinic Infrastructure and Practice Models That May Facilitate HIV Preexposure Prophylaxis (PrEP) Prescribing: A Qualitative Meta-Synthesis.医疗服务提供者对可能有助于开具HIV暴露前预防(PrEP)处方的诊所基础设施和实践模式的看法:一项定性元综合分析。
Health Promot Pract. 2022 Nov;23(6):999-1014. doi: 10.1177/15248399211038364. Epub 2021 Sep 22.
7
Achieving the "Ending the HIV Epidemic in the U.S." incidence reduction goals among at-risk populations in the South.实现美国南部高危人群中“终结美国艾滋病疫情”的发病率降低目标。
BMC Public Health. 2023 Apr 20;23(1):716. doi: 10.1186/s12889-023-15563-5.
8
Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.政策和县级层面与 HIV 暴露前预防用药的使用相关因素分析,美国,2018 年。
Ann Epidemiol. 2020 May;45:24-31.e3. doi: 10.1016/j.annepidem.2020.03.013. Epub 2020 Apr 3.
9
Potential contribution of PrEP uptake by adolescents 15-17 years old to achieving the "Ending the HIV Epidemic" incidence reduction goals in the US South.青少年 15-17 岁人群采用 PrEP 对实现美国南部“终结艾滋疫情”发病率降低目标的潜在贡献。
PLoS One. 2023 Nov 9;18(11):e0288588. doi: 10.1371/journal.pone.0288588. eCollection 2023.
10
Examination of HIV Preexposure Prophylaxis Need, Availability, and Potential Pharmacy Integration in the Southeastern US.美国东南部地区 HIV 暴露前预防需求、可及性及潜在的药房整合情况研究
JAMA Netw Open. 2023 Jul 3;6(7):e2326028. doi: 10.1001/jamanetworkopen.2023.26028.

本文引用的文献

1
PrEP Echo: A National Interdisciplinary Telementoring Program for HIV Prevention Through Practice Transformation.PrEP回声:一项通过实践转变进行艾滋病毒预防的全国跨学科远程指导计划。
AIDS Educ Prev. 2023 Jun;35(3):247-253. doi: 10.1521/aeap.2023.35.3.247.
2
Sexual Orientation and Gender Identity Data Completeness at US Federally Qualified Health Centers, 2020 and 2021.美国联邦合格健康中心 2020 年和 2021 年的性取向和性别认同数据完整性。
Am J Public Health. 2023 Aug;113(8):883-892. doi: 10.2105/AJPH.2023.307323. Epub 2023 Jun 15.
3
Health Care Coverage and Preexposure Prophylaxis (PrEP) Use Among Men Who Have Sex With Men Living in 22 US Cities With vs Without Medicaid Expansion, 2017.
医疗保险覆盖范围和男男性行为者使用暴露前预防(PrEP)在 22 个有和没有扩大医疗补助的美国城市中的情况,2017 年。
Am J Public Health. 2021 Apr;111(4):743-751. doi: 10.2105/AJPH.2020.306035. Epub 2021 Jan 21.
4
Impact of Medicaid Expansion on PrEP Utilization in the US: 2012-2018.医疗补助计划扩大对美国 PrEP 使用的影响:2012-2018 年。
AIDS Behav. 2021 Apr;25(4):1103-1111. doi: 10.1007/s10461-020-03070-2. Epub 2020 Oct 26.
5
Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.政策和县级层面与 HIV 暴露前预防用药的使用相关因素分析,美国,2018 年。
Ann Epidemiol. 2020 May;45:24-31.e3. doi: 10.1016/j.annepidem.2020.03.013. Epub 2020 Apr 3.
6
Ending the HIV Epidemic: A Plan for the United States.终结美国的艾滋病流行:一项计划
JAMA. 2019 Mar 5;321(9):844-845. doi: 10.1001/jama.2019.1343.
7
The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.2017 年第四季度美国暴露前预防用药的使用情况和暴露前预防用药的需求比。
Ann Epidemiol. 2018 Dec;28(12):841-849. doi: 10.1016/j.annepidem.2018.06.005. Epub 2018 Jun 15.
8
The Effects Of Medicaid Expansion Under The ACA: A Systematic Review.ACA 下医疗补助扩张的影响:系统评价。
Health Aff (Millwood). 2018 Jun;37(6):944-950. doi: 10.1377/hlthaff.2017.1491.
9
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.男男性行为人群 HIV 预防的暴露前药物预防。
N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.